This is a non-core endpoint: only basic statistics are computed.
Multiple superficial injuries of ankle and foot
ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
45 |
4. Check minimum number of eventsNone |
45 |
5. Include endpointsNone |
45 |
6. Filter based on genotype QC (FinnGen only) |
45 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesiones superficiales multae tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Multiple superficial injuries of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Superficial injury of ankle and foot
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45 | 29 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 44.34 | 46.28 | 40.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18
92
2.59
2.32
3.3
2.7
ng/l
82.8
28.8
0.32
13
51
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
13
59
2.69
2.08
1.2
1.3
iu/ml
35.9
31.0
—
7
21
(1761868) Lipid panel - Serum or Plasma
8
163
0.38
1.88
1.8
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
110
2.26
1.80
7.3
6.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
13
4.18
1.76
5.4
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
13
4.18
1.76
1.8
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
23
147
2.15
1.69
3.8
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
24
157
2.13
1.65
2.8
2.7
ug/l
118.7
75.7
0.67
24
152
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
20
3.30
1.64
1.0
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
98
2.18
1.60
4.6
5.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
79
2.12
1.36
1.6
2.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
13
72
2.13
1.32
3.1
3.9
%
92.9
101.0
0.48
13
72
(4010399)
5
19
2.83
1.25
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
6
26
2.50
1.23
10.2
3.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
36
0.00
1.20
0.0
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5
21
2.55
1.12
2.2
2.6
g/l
0.2
0.2
—
5
21
(3044640) Blood type and Crossmatch panel - Blood
13
77
1.97
1.10
2.2
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
54
2.10
1.06
2.3
2.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
24
179
1.73
0.96
7.6
6.6
e9/l
0.2
0.2
0.23
24
167
(3022217) INR in Platelet poor plasma by Coagulation assay
6
28
2.31
0.95
2.3
15.8
—
1.2
—
0
7
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
44
1.99
0.92
2.1
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
5
95
0.47
0.91
2.2
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
16
108
1.75
0.90
1.9
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
31
2.08
0.88
2.0
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6
31
2.08
0.88
5.0
2.0
%
25.0
25.7
—
6
26
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
100
1.75
0.87
2.0
1.9
pmol/l
100.3
93.0
—
8
54
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
32
2.01
0.85
1.8
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
59
1.89
0.84
1.2
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
27
0.00
0.80
0.0
2.6
—
16329.6
—
0
9
(3031040) Bacteria [#/volume] in Urine by Automated count
27
215
1.64
0.80
4.5
3.6
—
44.1
—
0
7
(3042936) Bacteria identified in Isolate by Culture
7
42
1.79
0.72
2.7
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
14
99
1.60
0.64
4.6
5.2
inr
1.0
1.1
—
5
39
(3000494) Fungus identified in Specimen by Culture
6
34
1.88
0.61
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
142
0.62
0.58
2.5
2.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13
171
0.66
0.53
5.1
6.8
umol/l
10.0
10.8
0.09
13
165
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
35
311
1.56
0.52
3.9
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
40
367
1.81
0.51
17.1
10.3
mg/l
17.2
19.0
0.23
31
274
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
6
92
0.60
0.48
1.8
1.5
mmol/l
1.9
1.3
—
6
81
(3019550) Sodium [Moles/volume] in Serum or Plasma
39
359
1.65
0.48
17.7
9.6
mmol/l
139.6
139.8
0.21
39
348
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
31
271
1.46
0.48
5.2
4.1
pmol/l
14.2
14.7
0.61
31
253
(36304419) Bacteria [Presence] in Urine
12
88
1.50
0.46
2.9
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
31
1.69
0.45
2.0
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
60
1.40
0.43
2.9
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.42
0.0
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
18
0.00
0.41
0.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
76
0.62
0.40
1.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
36
1.44
0.39
7.0
3.6
%
29.4
30.8
—
5
27
(3013512) EKG study
10
73
1.48
0.38
3.8
2.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
15
119
1.39
0.38
3.6
2.9
e6/l
8.6
66.3
—
10
78
(3015736) pH of Urine
10
131
0.70
0.37
2.9
2.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
39
362
1.58
0.37
18.0
9.6
mmol/l
4.0
3.9
0.32
39
351
(3013707) Erythrocyte sedimentation rate by Westergren method
28
248
1.34
0.35
4.6
4.0
mm/h
11.3
8.5
0.76
28
235
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
93
1.40
0.34
2.9
2.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
112
1.36
0.33
2.0
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
36
335
1.37
0.32
6.2
4.6
mu/l
1.6
1.7
0.20
36
317
(40768804) Tissue Pathology biopsy report
17
142
1.32
0.31
1.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
8
65
1.28
0.29
4.8
4.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
65
1.28
0.29
3.1
3.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
71
1.33
0.28
1.8
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
26
234
1.26
0.25
4.2
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
37
1.39
0.24
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
5
41
1.25
0.23
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
41
1.25
0.23
1.8
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
37
355
1.24
0.15
13.2
10.7
%
40.7
41.2
0.34
32
305
(3041096) Erythrocytes [Presence] in Urine by Automated
10
115
0.83
0.12
2.0
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
12
107
1.17
0.10
2.9
2.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
40
390
1.23
0.09
15.6
11.2
umol/l
81.2
71.6
0.33
40
390
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
8
73
1.12
0.08
1.5
1.9
mg/l
2.5
2.6
—
8
64
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
86
1.06
0.07
2.7
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
10
111
0.87
0.07
1.7
2.2
u/l
48.3
53.1
—
10
103
(3021601) Nitrite [Presence] in Urine by Test strip
18
169
1.11
0.06
3.6
4.3
estimate
0.0
0.0
—
6
33
(3044889) 12 lead EKG panel
22
231
0.91
0.06
3.3
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
17
173
0.97
0.00
2.4
3.2
estimate
0.0
0.0
—
5
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
114
0.95
0.00
3.4
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
17
172
0.98
0.00
2.4
3.0
estimate
0.0
0.0
—
6
34
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
24.5
—
0
9
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
107.3
—
0
8
(3018572) Chloride [Moles/volume] in Blood
0
7
0.00
0.00
0.0
7.1
—
106.9
—
0
7
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.9
—
1.0
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
6
0.00
0.00
0.0
2.3
—
5.1
—
0
6
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
49.9
—
0
9
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
6
0.00
0.00
0.0
2.3
—
62.7
—
0
6
(4094501)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.3
—
117.4
—
0
9
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
215.0
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
9.2
—
0
6
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
1.0
—
35.0
—
0
5
(40760888) Immunoglobulin light chains.free panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
85
0.93
0.00
3.0
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4306422)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
0
7
0.00
0.00
0.0
7.1
—
10.4
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
6.2
—
0
5
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
36
360
1.00
0.00
4.0
3.4
mmol/l
1.4
1.5
0.90
36
341
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.0
—
25.7
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT – Multiple superficial injuries of ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).